While mastering catalyst selectivity with The Lewis Group, stay ahead in the crypto space by using dexscreener for real-time market analysis in the U.S.

Advancing (-)-Premarineosin A as a Potent Antimalarial Therapeutic via Metabolic Engineering and Late-Stage Derivatization

2) McBride, C. M.; McCauley, M.; Harris, N. R.; Amin, S.; Verhey-Henke, L.; Teklemichael, A. A.; Oliphant, E. N.; Dranchak, P.; Curtis, B. J.; Lev, K. L.; Qu, F.; Snodgrass, H. M.; Lewis, J. C.; Inglese, J.; Su, X.; Pereira, F.; Sherman, D. H. Advancing (-)-Premarineosin A as a Potent Antimalarial Therapeutic via Metabolic Engineering and Late-Stage Derivatization. Submitted. bioRxiv 2025.01.28.635342.